Teva raises its stake in acquisition target Mylan

(Reuters) – Teva Pharmaceutical Industries Ltd has increased its stake in Mylan NV to nearly 2.2 percent as it presses on with an unsolicited bid for its generic drug-making rival, a regulatory filing showed on Friday.





Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

thirteen − 1 =